Stay updated on Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. Date stamps include 2026-03-18, 2026-03-19, and 2026-03, along with the future date 2029-12-10.
    Difference
    0.2%
    Check dated 2026-03-21T08:51:24.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T20:21:18.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page shows a new status: Active, not recruiting, and the revision version was updated to v3.4.2. Additionally, a contact phone number and the Recruiting label were removed.
    Difference
    0.3%
    Check dated 2026-02-13T11:47:51.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1, indicating a minor maintenance update rather than content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:24:17.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; the page content and layout appear unchanged.
    Difference
    0.0%
    Check dated 2026-01-29T10:13:06.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The Study Record Dates section now shows 'Last Update Posted' instead of 'Last Update Posted (Estimated)'.
    Difference
    0.0%
    Check dated 2026-01-22T06:32:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC 2nd-line Therapy Clinical Trial page.